- Home
- TDUP vs THQ Comparison
TDUP vs THQ Comparison
Compare TDUP & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TDUP | THQ |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.9M | 755.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TDUP | THQ |
|---|---|---|
| Price | $3.58 | $18.09 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 114.0K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | ★ 75.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $310,813,000.00 | N/A |
| Revenue This Year | $13.06 | N/A |
| Revenue Next Year | $10.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.53 | N/A |
| 52 Week Low | $2.25 | $15.14 |
| 52 Week High | $12.28 | $21.07 |
Technical Indicators
Market Signals| Indicator | TDUP | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 37.23 | 35.12 |
| Support Level | N/A | $17.68 |
| Resistance Level | $5.27 | $18.36 |
| Average True Range (ATR) | 0.35 | 0.26 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 13.25 | 18.75 |
Price Performance
Historical ComparisonAbout TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.